Immune therapy for ovarian cancer: Promise and pitfalls

Suzanne R. Thibodeaux; Tyler J. Curiel

doi:10.3109/08830185.2011.567361

Immune therapy for ovarian cancer: Promise and pitfalls

Suzanne R. Thibodeaux, Tyler J. Curiel

Medicine

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Abstract

This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.

Original language	English (US)
Pages (from-to)	102-119
Number of pages	18
Journal	International Reviews of Immunology
Volume	30
Issue number	2-3
DOIs	https://doi.org/10.3109/08830185.2011.567361
State	Published - Apr 2011

Keywords

Ovarian cancer
immune therapy
immunity
review

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.3109/08830185.2011.567361

Cite this

@article{94380f3653dc428381ca4c6550c337ca,

title = "Immune therapy for ovarian cancer: Promise and pitfalls",

abstract = "This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.",

keywords = "Ovarian cancer, immune therapy, immunity, review",

author = "Thibodeaux, {Suzanne R.} and Curiel, {Tyler J.}",

year = "2011",

month = apr,

doi = "10.3109/08830185.2011.567361",

language = "English (US)",

volume = "30",

pages = "102--119",

journal = "International Reviews of Immunology",

issn = "0883-0185",

publisher = "Informa Healthcare",

number = "2-3",

}

TY - JOUR

T1 - Immune therapy for ovarian cancer

T2 - Promise and pitfalls

AU - Thibodeaux, Suzanne R.

AU - Curiel, Tyler J.

PY - 2011/4

Y1 - 2011/4

N2 - This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.

AB - This review covers immune and anatomic considerations specific for ovarian cancer immune therapy. Prior approaches and potential reasons for lack of better efficacy are discussed, along with newer approaches in pre-clinical and early clinical development. Potential means for future investigations and means to integrate immune with other approaches are discussed.

KW - Ovarian cancer

KW - immune therapy

KW - immunity

KW - review

UR - http://www.scopus.com/inward/record.url?scp=79955828984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955828984&partnerID=8YFLogxK

U2 - 10.3109/08830185.2011.567361

DO - 10.3109/08830185.2011.567361

M3 - Article

C2 - 21557637

AN - SCOPUS:79955828984

VL - 30

SP - 102

EP - 119

JO - International Reviews of Immunology

JF - International Reviews of Immunology

SN - 0883-0185

IS - 2-3

ER -

Immune therapy for ovarian cancer: Promise and pitfalls

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this